Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 18/20 | 0.41 |
| ▸ | SLC5A1 | P13866 | 15/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20124376 | 0.83 | SLC5A2 (0.54) | SLC5A2SLC5A1 | |
| SCHEMBL21765097 | 0.81 | SLC5A2 (0.44) | SLC5A2SLC5A1 | |
| SCHEMBL23453177 | 0.79 | SLC5A2 (0.37) | SLC5A2SLC5A1 | |
| SCHEMBL24981125 | 0.77 | SLC5A2 (0.48) | SLC5A2SLC5A1 | |
| SCHEMBL25665514 | 0.76 | SLC5A2 (0.49) | SLC5A2SLC5A1 | |
| SCHEMBL20124375 | 0.74 | SLC5A2 (0.45) | SLC5A2SLC5A1 | |
| SCHEMBL25852980 | 0.74 | SLC6A2 (0.33) | SLC5A2SLC5A1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24952274 | 0.74 | SLC5A2 (0.36) | SLC5A2SLC5A1 | |
| SCHEMBL27820660 | 0.73 | SLC5A2 (0.52) | SLC5A2SLC5A1 | |
| SCHEMBL27358383 | 0.73 | SLC5A2 (0.47) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3634970-B1 | NOVEL PROCESS FOR PREPARATION OF EMPAGLIFLOZIN OR ITS CO-CRYSTALS, SOLVATES AND THEIR POLYMORPHS THEREOF | LAURUS LABS LTD (IN) | 2023-07-19 | — | — | EP | disclosed |